Related Experiment Video
Updated: May 22, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Pulmonary Infections in Adults: Nosocomial Pneumonia
Thomas M File1, Julio A Ramirez2
1Infectious Disease Division - Summa Health, Akron, OH.
Abstract:
Nosocomial pneumonia, which includes hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), is associated with high morbidity and mortality. HAP occurs 48 hours or more after admission and may require intubation and mechanical ventilation. VAP occurs more than 48 hours after mechanical ventilation is initiated. The mortality rate of VAP and ventilated HAP ranges from 15% to 30%, depending on severity. Diagnosis is based on a new pulmonary infiltrate associated with clinical evidence of infection such as new-onset fever, purulent sputum, leukocytosis, and decline in oxygenation. Optimal management includes identification of the causative pathogen, early empiric antimicrobial therapy directed against likely pathogens, and de-escalation of treatment once a pathogen is identified. The standard treatment duration is 7 days for patients who are improving clinically. Effective methods to prevent VAP include washing hands adequately between patient contacts, maintaining semirecumbent patient positioning, avoiding gastric overdistention, providing continuous subglottic suctioning for patients on mechanical ventilation, limiting stress-ulcer prophylaxis, and practicing daily oral care with toothbrushing.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...